Every Form 4 that Diversified Healthcare Tr (DHC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DHC filings page.
JONES LISA HARRIS reported acquisition or exercise transactions in this Form 4 filing.
DIVERSIFIED HEALTHCARE TRUST director Lisa Harris Jones received 12,401 Common Shares of Beneficial Interest as an equity award. The shares were granted at no cash cost under the company’s equity compensation plan, bringing her direct holdings to about 170,287 shares. This total includes 392.041 shares accumulated through a dividend reinvestment plan.
SOMERS JEFFREY P. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Jeffrey P. Somers received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The grant was at a stated price of $0.00 per share, bringing his direct holdings to 177,079 shares.
Neher Dawn K. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Dawn K. Neher received an award of 12,401 Common Shares of Beneficial Interest as equity compensation. The shares were granted at no cash cost to her under the company’s equity compensation plan and increase her direct holdings to 78,579 shares.
Bilotto Christopher J. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust President and CEO Christopher J. Bilotto received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 at no cash cost, as part of the company’s equity compensation plan. After this grant and shares added through a dividend reinvestment plan, his direct holdings total about 279,246.802 shares, including 560.894 shares accumulated from reinvested dividends since his last ownership report.
PORTNOY ADAM D. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Adam D. Portnoy reported an equity-based compensation grant and updated holdings. He received 12,401 Common Shares of Beneficial Interest as an award under the company’s equity compensation plan, bringing his directly held stake to 427,557.55 shares.
The filing also lists 23,250,019 Common Shares of Beneficial Interest held indirectly through ABP Trust. Mr. Portnoy, as sole trustee, officer and controlling shareholder of ABP Trust, may be deemed a beneficial owner of those shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
Felder Alan L. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Alan L. Felder received an award of 12,401 Common Shares of Beneficial Interest on 2026-06-10. The shares were granted at no cash cost to him pursuant to the company’s equity compensation plan.
Following this grant, Felder directly holds 75,124 common shares, as reported in the filing.
Hollis Phyllis M. reported acquisition or exercise transactions in this Form 4 filing.
Diversified Healthcare Trust director Phyllis M. Hollis received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 under the company’s equity compensation plan. The award was granted at no cash cost per share as part of her director compensation.
After this grant, she directly holds 100,147.703 common shares. This total includes 666.634 shares accumulated through a dividend reinvestment plan since her prior Section 16 filing, showing ongoing participation in the company’s reinvestment program in addition to the new equity award.
Diversified Healthcare Trust reported that its President, CEO and Director Christopher J. Bilotto purchased 20,000 common shares of beneficial interest on 12/15/2025 at a weighted average price of $4.886 per share, in multiple transactions priced between $4.88 and $4.89.
After these purchases, he beneficially owns 266,284.908 DHC shares directly, which includes 385.018 shares acquired through a dividend reinvestment plan since his last Section 16 filing.
Matthew C. Brown, the Chief Financial Officer and Treasurer of Diversified Healthcare Trust (ticker DHC), reported a sale of common shares on 09/16/2025. The Form 4 shows 9,711 shares were disposed of at a reported price of $4.37 per share, reducing his beneficial ownership to 113,954 shares. The filing states the disposition code is F(1), and the explanatory note says the transaction represents withholding of shares to satisfy tax withholding obligations upon vesting.
This filing is a routine insider tax-withholding sale rather than an open-market trade, and it was signed by Mr. Brown on 09/18/2025.
Christopher J. Bilotto, who serves as President and CEO and a director of Diversified Healthcare Trust (ticker shown in filing as NASDAQ:DHC), reported a transaction on 09/16/2025 disposing of 17,091 common shares at a price of $4.37 per share. The filing states the shares were withheld to pay a tax liability related to the vesting of previously issued securities. After the withholding, the report shows 245,899.89 common shares beneficially owned by Mr. Bilotto. The Form 4 is signed by the reporting person for this single-person filing.
Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ: DHC), reported a sale of 15,226 common shares on 09/16/2025 at a price of $4.37 per share. The filing lists 415,156.55 shares as his direct beneficial ownership following the transaction and indicates an indirect interest of 23,250,019 shares held by ABP Trust, for which Mr. Portnoy is sole trustee; he disclaims beneficial ownership except to the extent of his pecuniary interest. The filing explains the sale code as F, reflecting withholding of shares to satisfy a tax liability arising from vesting. The Form 4 was signed on 09/18/2025.